Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis
Tatsunori Hanai, Makoto Shiraki, Takao Miwa, et al.
Hepatology Research (2018) Vol. 49, Iss. 1, pp. 82-95
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Jennifer C. Lai, Puneeta Tandon, William Bernal, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1611-1644
Open Access | Times Cited: 431
Sarcopenia in cirrhosis: from pathogenesis to interventions
Maryam Ebadi, Rahima A. Bhanji, Vera C. Mazurak, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 10, pp. 845-859
Open Access | Times Cited: 239
Management of Portal Hypertension
Anand V. Kulkarni, Atoosa Rabiee, Arpan Mohanty
Journal of Clinical and Experimental Hepatology (2022) Vol. 12, Iss. 4, pp. 1184-1199
Open Access | Times Cited: 23
Pharmacotherapy for Cirrhosis in Japan
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
Portal hypertension & cirrhosis (2025)
Open Access
Drug‐related sarcopenia as a secondary sarcopenia
Masafumi Kuzuya
Geriatrics and gerontology international/Geriatrics & gerontology international (2023) Vol. 24, Iss. 2, pp. 195-203
Open Access | Times Cited: 10
Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma
Ayu Nagamatsu, Takumi Kawaguchi, Keisuke Hirota, et al.
Hepatology Research (2019) Vol. 49, Iss. 12, pp. 1427-1440
Closed Access | Times Cited: 29
Clinical impact of sarcopenia assessment in patients with liver cirrhosis
Giovanni Marasco, Elton Dajti, Federico Ravaioli, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 4, pp. 377-388
Closed Access | Times Cited: 25
Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
Hiroteru Kamimura, Takeki Sato, Kazuki Natsui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1425-1425
Open Access | Times Cited: 18
Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, et al.
Journal of Clinical Medicine (2018) Vol. 7, Iss. 12, pp. 553-553
Open Access | Times Cited: 22
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema
Masanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 7, pp. 1229-1237
Closed Access | Times Cited: 21
The challenges of ascites management: An Indian perspective
Anand V. Kulkarni, Madhumita Premkumar, D. Nageshwar Reddy, et al.
Clinical Liver Disease (2022) Vol. 19, Iss. 6, pp. 234-238
Open Access | Times Cited: 12
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis
Maiko Namba, Akira Hiramatsu, Hiroshi Aikata, et al.
Journal of Gastroenterology (2019) Vol. 55, Iss. 2, pp. 217-226
Closed Access | Times Cited: 19
Independent Association Between Use of Proton Pump Inhibitors and Muscle Wasting in Patients with Heart Failure: A Single-Center, Ambispective, Observational Study
Katsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
Drugs & Aging (2023) Vol. 40, Iss. 8, pp. 731-739
Closed Access | Times Cited: 6
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management
Mazen Elsheikh, Ahmed El Sabagh, Islam Mohamed, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 46, pp. 6028-6048
Open Access | Times Cited: 6
Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure
Ippei Nakano, Masaya Tsuda, Shintaro Kinugawa, et al.
Journal of Cardiology (2020) Vol. 76, Iss. 1, pp. 109-114
Open Access | Times Cited: 15
Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors
Ryo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
Circulation Journal (2023) Vol. 88, Iss. 1, pp. 10-19
Open Access | Times Cited: 4
Coexistence of sarcopenia and self‐reported weight loss is a powerful predictor of mortality in older patients with heart failure
Katsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2023) Vol. 24, Iss. 1, pp. 95-101
Closed Access | Times Cited: 4
Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond
Hamza Tahir, Manisha Verma, Bakhtawer Siraj, et al.
Current Treatment Options in Gastroenterology (2024) Vol. 22, Iss. 4, pp. 218-238
Closed Access | Times Cited: 1
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
Yoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, et al.
Clinical Drug Investigation (2018) Vol. 39, Iss. 1, pp. 45-54
Open Access | Times Cited: 11
Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020
Tatsunori Hanai, Kayoko Nishimura, Takao Miwa, et al.
Journal of Gastroenterology (2021) Vol. 56, Iss. 10, pp. 928-937
Closed Access | Times Cited: 9
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, et al.
BMJ Open Gastroenterology (2023) Vol. 10, Iss. 1, pp. e001120-e001120
Open Access | Times Cited: 3
Effect of furosemide on muscle cramps in patients with liver cirrhosis
Yasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 1, pp. 76-81
Open Access | Times Cited: 8
Durable response without recurrence to Tolvaptan improves long-term survival
Masato Nakai, Goki Suda, Akinori Kubo, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 12, pp. 1150-1161
Closed Access | Times Cited: 7
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis
Yoshihito Uchida, Shohei Tsuji, Hayato Uemura, et al.
Hepatology Research (2020) Vol. 50, Iss. 11, pp. 1264-1274
Closed Access | Times Cited: 7
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis
Yoshihito Uchida, Mie Inao, Shohei Tsuji, et al.
Hepatology Research (2020) Vol. 50, Iss. 12, pp. 1355-1364
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top